close
Please Support Mad In America
Please Support Mad In America
One Time Monthly Yearly
Please make a selection.
{{amounts[0] | currency }} / {{formData.donationPeriod}}
Select
{{amounts[1] | currency }} / {{formData.donationPeriod}}
Select
{{amounts[2] | currency }} / {{formData.donationPeriod}}
Select
attach_money
Please enter an amount.
Select

Use one of the links below to enter a one-time donation at an amount of your choosing (one-time donations will not automatically remove the "Support Us" popup, but if you write to us we can remove it for you manually).

Credit Card
PayPal

Madinamerica.com does not host advertisements or sell any data about our readers. As such, our ongoing operations are funded entirely by the support of our readers. With your support, you won't see this again for a year.

No Thanks

Second-Generation Antipsychotics Just as Likely as Older Drugs to Cause EPS

In a study of an earlier randomized controlled trial of antipsychotics, researchers from Yale and the U.K found that second-generation antipsychotics were as likely as the first-generation antipsychotics to cause extrapyramidal symptoms. However, patients in the second-generation group were "dramatically" (30-fold) less likely to be prescribed medication for the management of these side effects. First-generation antipsychotics have the potential to "avoid life-shortening metabolic disturbances" caused by second-generation antipsychotics, but current psychiatrists have little or no experience with the prior generation of antipsychotics, the researchers said. Results will appear in the British Journal of Psychiatry.

Article → 

Recent News

Recent Blogs

Around The Web

Related Posts

Second-Generation Antipsychotics Just as Likely as Older Drugs to Cause EPS Comments RSS

One thought on “Second-Generation Antipsychotics Just as Likely as Older Drugs to Cause EPS

Leave a Reply